Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 Jeffrey L. Cummings

ISBN: 9780521862530

Published: annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The seriesMorePublished annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored

Hardcover

184 pages


Description

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006  by  Jeffrey L. Cummings

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 by Jeffrey L. Cummings
annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The seriesMorePublished annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored | Hardcover | PDF, EPUB, FB2, DjVu, AUDIO, mp3, RTF | 184 pages | ISBN: 9780521862530 | 3.71 Mb

Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The seriesMorePublished annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments.

Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. This volume was first published in 2006.



Enter the sum





Related Archive Books



Related Books


Comments

Comments for "Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006":


gimgolina.pl

©2013-2015 | DMCA | Contact us